3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
2
Other hematologic neoplasm
2
Myeloid
1
Classical hematology
1
Conditions
Thrombocytopenia
1
Myelodysplastic Syndromes
1
Leukemia
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Cyclophosphamide
21
fludarabine phosphate
15
Cyclosporine
13
Antilymphocyte Serum
13
Peripheral Blood Stem Cell Transplantation
12
Busulfan
12
Whole-Body Irradiation
11
Mycophenolic Acid
10
Filgrastim
8
fludarabine
7
Methotrexate
7
Melphalan
7
Therapeutics
5
Radiotherapy
5
Cytarabine
5
Blood Specimen Collection
5
Tacrolimus
4
Psychiatric Rehabilitation
4
Methylprednisolone
4
Cord Blood Stem Cell Transplantation
4
thymoglobulin
3
Stem Cell Transplantation
3
Palliative Care
3
Imatinib Mesylate
3
Granulocyte Colony-Stimulating Factor
3
Flow Cytometry
3
Dexamethasone
3
Behavior Therapy
3
Aprepitant
3
sargramostim
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Platelet Transfusion
×
Myeloid
×
Clear all
NCT01615146
2015-09-02
OPTIMAL
Ottawa Hospital Research Institute
Phase NA
Terminated
9 enrolled